Metraipolis › archive › dc_e812a02add48

Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets — Europe PMC PMID:41799079

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41799079
DOI
10.1021/acsomega.5c11179
License (as archived)
solo-consultazione
Archived
2026-11-05T15:33:45.326Z
SHA-256 of the archived text
4b192f4200f0d26022f8669bbb3bd586e76744179fb3360f4e325b7f88263980
Stable URL of this page
https://metraipolis.com/documento/dc_e812a02add48

How to cite

Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets — Europe PMC PMID:41799079 — Europe PMC (en), https://europepmc.org/article/MED/41799079 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e812a02add48 (Metraipolis archive dc_e812a02add48, sha256 4b192f4200f0d26022f8669bbb3bd586e76744179fb3360f4e325b7f88263980)
BibTeX
@misc{dce812a02add48,
  title = {Evaluation of USP 3 Apparatus to Develop Biopredictive Fasted and Fed Dissolution Methods for Extended-Release Desvenlafaxine Succinate Tablets — Europe PMC PMID:41799079},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41799079},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e812a02add48; sha256 4b192f4200f0d26022f8669bbb3bd586e76744179fb3360f4e325b7f88263980},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41799079. Agents can read the archived copy with the MCP tool read_document.